1-13773141-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001393986.1(PRDM2):c.575C>T(p.Thr192Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000121 in 1,576,126 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001393986.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRDM2 | NM_001393986.1 | c.575C>T | p.Thr192Ile | missense_variant | 7/10 | ENST00000311066.10 | NP_001380915.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRDM2 | ENST00000311066.10 | c.575C>T | p.Thr192Ile | missense_variant | 7/10 | 5 | NM_001393986.1 | ENSP00000312352.6 |
Frequencies
GnomAD3 genomes AF: 0.000257 AC: 39AN: 152010Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000172 AC: 37AN: 214674Hom.: 0 AF XY: 0.000164 AC XY: 19AN XY: 115628
GnomAD4 exome AF: 0.000106 AC: 151AN: 1424116Hom.: 0 Cov.: 30 AF XY: 0.0000948 AC XY: 67AN XY: 706430
GnomAD4 genome AF: 0.000257 AC: 39AN: 152010Hom.: 0 Cov.: 32 AF XY: 0.000296 AC XY: 22AN XY: 74214
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2023 | The c.575C>T (p.T192I) alteration is located in exon 7 (coding exon 6) of the PRDM2 gene. This alteration results from a C to T substitution at nucleotide position 575, causing the threonine (T) at amino acid position 192 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at